Thus, to investigate the specific role of IFNLR1 expression and pathway activation in NSCLC, we established a CRISPR-mediated transcriptional activation approach (CRISPRa) (Figure 6A) targeting the promotor region of IFNLR1. The gene discussed is IFNLR1; the disease is non-small cell lung carcinoma.